Medicine and Dentistry
Pediatrics
100%
Liver Disease
60%
Liver Transplantation
52%
Cystic Fibrosis
48%
Fibrosis
26%
Liver Biopsy
24%
Liver Graft
23%
Diseases
18%
Biopsy Technique
18%
Hepatoblastoma
18%
Liver Cirrhosis
17%
Cholestasis
17%
Transplantation
17%
Biological Marker
16%
Primary Sclerosing Cholangitis
16%
Pediatrics Patient
14%
Platelet
14%
Acute Liver Failure
13%
Neonatal Infant
12%
Diagnosis
12%
Liver Fibrosis
11%
Prospective Study
9%
Hepatocellular Carcinoma
8%
Malignant Neoplasm
8%
Infection
8%
Gamma-Glutamyl Transpeptidase
8%
Overall Survival
8%
Quality of Life
8%
Nonalcoholic Fatty Liver
8%
Weight Management
8%
Heart Graft
8%
Long Term Survival
8%
Fatty Liver
8%
Hepatobiliary Disease
8%
Blood Stasis
8%
Non Invasive Procedure
8%
Patient-Reported Outcome
8%
Fontan Procedure
8%
Gastrointestinal Tract
8%
Late Effect
8%
Biliary Tract Disease
8%
Glycogen Storage Disease Type IV
8%
Toddlers
8%
Fibrosarcoma
8%
Family Relationship
8%
Posttransplant Lymphoproliferative Disease
8%
Gastrointestinal Disease
8%
Bile Salt Export Pump
8%
Gut
8%
Egg Lecithin
8%
Keyphrases
Liver Transplantation
56%
Liver
49%
Cystic Fibrosis
40%
Ultrasound
34%
Pediatric
30%
Liver Biopsy
19%
Pediatric Liver Transplantation
18%
Advanced Liver Disease
17%
High Risk
17%
Polycystic Liver Disease
16%
Primary Sclerosing Cholangitis
16%
Pediatric Hepatoblastoma
16%
NK Genes
16%
Gene Complexes
16%
Liver Disease
15%
Worse Outcome
14%
Ultrasound Pattern
14%
Cirrhosis
13%
Working Diagnosis
13%
Pediatric Subjects
13%
Pediatric Patients
13%
Hepatoblastoma
12%
Natural Killer Cells
12%
Liver Fibrosis
12%
Pediatric Liver Transplant
11%
Pediatric Population
10%
Fibrosis
10%
Risk Factors
10%
Liver Ultrasound
9%
Pancreas
9%
Murine CMV
9%
Pediatric Donor
9%
Hepatocellular Carcinoma
8%
Liver Stiffness
8%
Liver Outcomes
8%
Advanced Fibrosis
8%
Listing Status
8%
Deceased Donor
8%
Non-alcoholic Fatty Liver Disease (NAFLD)
8%
Older Donors
8%
Fontan Procedure
8%
Gastrointestinal Diseases
8%
Random Forest Analysis
8%
Cytokine Production
8%
Disease Biomarker Detection
8%
Fatty Liver Disease
8%
Hepatic Disease
8%
Clinical Model
8%
Breath Sampling
8%
Non-invasive Method
8%
